Natalie S. Callander, MD, on Relapsed/Refractory Multiple Myeloma: Expert Perspective on New Research

Posted: Tuesday, August 15, 2017

Natalie S. Callander, MD, of the University of Wisconsin Carbone Cancer Center, discusses two studies that are representative of efforts being made in treating relapsed/refractory disease.